BioNote (XKRX:377740) YoY EBITDA Growth : -66.73% (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is BioNote YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. BioNote's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -66.73%.

BioNote's EBITDA per Share for the three months ended in Mar. 2025 was ₩81.81.

BioNote YoY EBITDA Growth Historical Data

The historical data trend for BioNote's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNote YoY EBITDA Growth Chart

BioNote Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

44.78

25.18

-52.11

-122.10

181.21

BioNote Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															201.43	117.73	-71.40	127.29	-66.73

BioNote YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

BioNote's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(801.765	-	-987.334)	/	\| -987.334 \|
=	181.21 %

BioNote's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(81.81	-	245.892)	/	\| 245.892 \|
=	-66.73 %

BioNote YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of BioNote's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNote Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

22, Samsung 1-ro 4-gil, Gyeonggi-do, Hwaseong-si, KOR

Website

https://www.bionote.co.kr

BioNote Inc is a manufacturer of diagnostic kits and equipment for animal diseases and is equipped with a wide product portfolio, from initial screening tests to molecular diagnosis. Its animal diagnostics products comprise of Vcheck F, Vcheck M, Vcheck C, Rapid, and ELISA.

BioNote Headlines

No Headlines